Data / Form D filings / ABVC BIOPHARMA, INC.
ABVC BIOPHARMA, INC.: Form D filings
ABVC BIOPHARMA, INC., a biotechnology company in Fremont, CA, filed 3 Form D notices with the SEC between 2018 and 2024. The latest, on May 28, 2024, reports $750,000 sold of a $750,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 44370 OLD WARM SPRINGS BLVD., Fremont, CA, 94538
- Phone
- (510) 668-0881
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1173313
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 28, 2024 | New notice | $750,000 | $750,000 | 1 | May 23, 2024 | sec.gov | |
| Mar 2, 2023 | New notice | $3,704,167 | $3,175,000 | $529,167 | 1 | Feb 23, 2023 | sec.gov |
| Jul 27, 2018 | New notice | $1,100,000 | $550,000 | $550,000 | 2 | May 9, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eugene Jiang | Director | |
| Tsung-Shann (T.S.) Jiang | Director | |
| Hsin-Hui Miao | Director | |
| Uttam Patil | Executive Officer | |
| Norimi Sakamoto | Director | |
| Che-Wei Hsu | Director | |
| Leeds Chow | Director | |
| Yoshinobu Odaira | Director | |
| Yu-Min (Francis) Chung | Director | |
| Yen-Hsin Chou | Director | |
| Chang-Jen Jiang | Director | |
| Shuling Jiang | Director | |
| Tsang Ming Jiang | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 27, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ABVC BIOPHARMA, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.